Company overview
Journey is a global design and innovation agency offering interconnected services in Strategy, Story, Design, Technology, and Delivery. They create multidimensional experiences (MDX) connecting people, brands, and culture. While not exclusively focused on life sciences or pharma, their expertise supports pharma R&D and procurement leaders in crafting innovative customer journeys and brand experiences.
Journey is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include journey agency, design innovation, pharma strategy, customer journey, brand experiences.
Structured facts
- Website
- https://journey.world
- Markets served
- United States & Americas
- Keywords
- journey agency, design innovation, pharma strategy, customer journey, brand experiences
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What services does Journey offer for pharma innovation?
- Journey provides services across Strategy, Story, Design, Technology, and Delivery to shape multidimensional experiences connecting people, brands, and culture.
- How can Journey support customer journey management in life sciences?
- Journey's design and innovation capabilities enable the creation of interconnected experiences, potentially adaptable for pharma customer journeys through strategy and technology integration.
- What industries does Journey serve, including pharma?
- As a global agency, Journey focuses on brand and cultural connections, with applications for life sciences in design, technology, and delivery services.
Related editorial coverage
- Exclusive: FDA issues industry-friendly gene therapy guidance: What BD teams need to know
- Opinion: I led the CDC response to the 2014 Ebola epidemic. The new outbreak needs massive
- Amish Health Beliefs: Vaccines, Costs, and Pharma Strategy Insights
- STAT+: Newer GLP-1s, pushback on research cuts, and a protest
- OHRP Underfunding Risks Human Subject Protection in 2026
- ASCO26: Gastrointestinal Cancers Enter the Limelight Amid Key Readout Surge
Explore lab tools and QA/QC resources for R&D teams.
